Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use lamotrigine extended-release tablets safely and effectively. See full prescribing information for lamotrigine extended-release tablets. Lamotrigine Extended-Release TabletsInitial U.S. Approval: 1994
Medication labelWhy this: Advisory · dailymed-prescription
Lamotrigine extended-release tablets are indicated as adjunctive therapy for partial onset seizures with or without secondary generalization in patients ≥13 years of age. Safety and effectiveness of lamotrigine extended-release tablets for use in patients less than 13 years of age have not been established.
- generic_name
- lamotrigine
- product_names
- Lamotrigine
- ndc
- 55648-271, 55648-274, 55648-273, 55648-272, 55648-275, 55648-271-01, 55648-271-02, 55648-271-04, 55648-274-01, 55648-274-02, 55648-274-03, 55648-273-01, 55648-273-02, 55648-273-04, 55648-272-01, 55648-272-02, 55648-272-04, 55648-275-01, 55648-275-02, 55648-275-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en